Avestar Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$574K Sell
2,600
-113
-4% -$31.3K 0.03% 346
2026
Q1
$801K Buy
2,713
+20
+0.7% +$5.94K 0.05% 265
2025
Q4
$735K Sell
2,693
-8
-0.3% -$2.17K 0.05% 269
2025
Q3
$730K Sell
2,701
-145
-5% -$39.5K 0.05% 276
2025
Q2
$784K Buy
2,846
+946
+50% +$257K 0.05% 259
2025
Q1
$504K Sell
1,900
-280
-13% -$69.1K 0.04% 284
2024
Q4
$507K Buy
2,180
+225
+12% +$51.7K 0.04% 290
2024
Q3
$431K Buy
1,955
+34
+2% +$7.04K 0.04% 279
2024
Q2
$378K Buy
1,921
+548
+40% +$113K 0.04% 294
2024
Q1
$296K Buy
1,373
+192
+16% +$40.3K 0.03% 342
2023
Q4
$255K Buy
+1,181
New +$252K 0.03% 321
2019
Q3
Sell
-326
Closed -$57K 302
2019
Q2
$57K Buy
326
+3
+0.9% +$553 0.04% 276
2019
Q1
$49K Buy
323
+13
+4% +$2.3K 0.03% 287
2018
Q4
$54K Buy
310
+32
+12% +$5.91K 0.04% 255
2018
Q3
$44K Sell
278
-57
-17% -$9.6K 0.03% 287
2018
Q2
$48K Sell
335
-18
-5% -$2.94K 0.03% 281
2018
Q1
$53K Sell
353
-19
-5% -$3.02K 0.03% 245
2017
Q4
$50K Buy
+372
New +$53K 0.04% 250

Other funds holding CME

Avestar Capital's CME Position: Q2 2026 in Review

Avestar Capital reduced its CME Group (CME) stake by 4.2% in Q2 2026, selling an estimated $31.3K and leaving 2,600 shares worth $574K. The position accounts for 0.03% of the portfolio, ranked #346.

Avestar Capital first reported a position in CME in Q4 2017 and has held it in 18 quarters since. The position peaked at $801K in Q1 2026. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Avestar Capital held 2,600 shares of CME Group worth $574K as of Q2 2026.
  • Avestar Capital sold 113 CME Group shares in Q2 2026, an estimated $31.3K.
  • CME Group made up 0.03% of Avestar Capital's portfolio in Q2 2026, its #346 holding.
  • Avestar Capital first reported a position in CME Group in Q4 2017 and has held it in 18 quarters since.
  • Avestar Capital's CME Group position peaked at $801K in Q1 2026.
  • 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.